Updates
Perspectives and deep dives on the models powering AI for life science discovery.
Updates
This update enables structural biologists and drug discovery researchers to predict complex 3D biomolecular structures through a guided workflow inside Vecura, eliminating the need to manage complex GPU infrastructure and environment setups.
Updates
This update integrates the deep-learning-augmented docking tool gnina into Vecura, enabling researchers to perform advanced, CNN-powered molecular docking without the need to manage complex infrastructure or GPU acceleration.
Updates
This update enables computational biologists, medicinal chemists, and drug discovery researchers to predict small molecule binding poses and affinities through a guided workflow inside Vecura, without setting up complex technical infrastructure.
Updates
This update enables researchers and drug discovery teams to streamline antibody and nanobody design through a guided, high-performance workflow inside Vecura, eliminating the need to manage complex underlying technical infrastructure.
Updates
This update enables computational scientists and medicinal chemists to streamline fragment-based lead optimization through a guided, accessible workflow inside Vecura, eliminating the need to manage complex underlying technical infrastructure.
Updates
This update empowers drug discovery researchers to generate and optimize novel molecular analogs directly within the Vecura platform, streamlining lead optimization workflows without the need for complex infrastructure setup.
Updates
This update enables structural biologists and protein engineers to explore protein flexibility and capture metastable conformational states directly within Vecura, removing the burden of managing complex computational pipelines.
Updates
This update enables structural biologists, drug discovery researchers, and computational biochemists to predict the all-atom 3D structure of biomolecular complexes — proteins, DNA, RNA, ligands, and ions — through a guided workflow inside Vecura, without setting up complex GPU infrastructure or managing alignment pipelines.
Updates
This integration enables structural biologists and drug discovery researchers to generate diverse conformational ensembles of biomolecular complexes through an intuitive workflow on Vecura, eliminating the need for complex computational infrastructure setup.
Updates
This update empowers researchers to perform advanced antibody CDR co-design directly within Vecura, streamlining the generation of structurally optimized, antigen-specific antibody candidates without the need for complex local infrastructure.
Updates
This update enables therapeutic antibody and TCR developers to predict 3D structures of antibodies, nanobodies, and T-cell receptors through a guided workflow inside Vecura, without setting up complex technical infrastructure.
Updates
This update enables researchers and computational biologists to generate high-fidelity, all-atom structural predictions for complex biomolecular assemblies through a guided, accessible workflow inside Vecura, removing the need to manage complex, resource-intensive technical infrastructure.